Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese
- PMID: 21703181
- DOI: 10.1016/j.jhep.2011.04.022
Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese
Abstract
Background & aims: Morbid obesity is frequently associated with low grade systemic inflammation, increased macrophage accumulation in adipose tissue (AT), obstructive sleep apnea (OSA), and nonalcoholic fatty liver disease (NAFLD). It has been suggested that chronic intermittent hypoxia (CIH) resulting from OSA could be an independent factor for early stage of NAFLD in addition to other well-recognized factors (dyslipidemia or insulin resistance). Moreover, macrophage accumulation in AT is associated with local hypoxia in fat tissue. We hypothesized that the association between CIH and morbid obesity could exert additional specific deleterious effects both in the liver and adipose tissues.
Methods: One hundred and one morbidly obese subjects were prospectively recruited and underwent bariatric surgery during which a liver needle biopsy as well as surgical subcutaneous and omental AT biopsies were obtained. Oxygen desaturation index (ODI) quantified the severity of nocturnal CIH.
Results: Histopathologic analysis of liver biopsies demonstrated that NAFLD lesions (ballooning of hepatocytes, lobular inflammation), NAFLD activity score (NAS), and fibrosis were significantly more severe in patients with the highest ODI tertile (p values ≤0.001 for all hepatic lesions). In multivariate analysis, after adjustment for age, obesity, and insulin resistance status, CIH remained independently associated with hepatic fibrosis, fibroinflammation, and NAS. By contrast, no association was found between CIH, macrophage accumulation, and adipocytes size in both subcutaneous and omental adipose tissue.
Conclusions: In morbidly obese patients, CIH was strongly associated with more severe liver injuries but did not worsen obesity induced macrophage accumulation in adipose tissue depots.
Copyright © 2011 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Comment in
-
Chronic intermittent hypoxia: a breath of fresh air in the understanding of NAFLD pathogenesis.J Hepatol. 2012 Jan;56(1):20-2. doi: 10.1016/j.jhep.2011.09.002. Epub 2011 Sep 16. J Hepatol. 2012. PMID: 21925128 No abstract available.
Similar articles
-
Nonalcoholic fatty liver disease, nocturnal hypoxia, and endothelial function in patients with sleep apnea.Chest. 2014 Mar 1;145(3):525-533. doi: 10.1378/chest.13-0938. Chest. 2014. PMID: 24264333
-
Influence of obstructive sleep apnea on fatty liver disease: role of chronic intermittent hypoxia.Respir Care. 2012 Feb;57(2):244-9. doi: 10.4187/respcare.01184. Epub 2011 Jul 12. Respir Care. 2012. PMID: 21762556
-
Macrophage activation marker soluble CD163 and non-alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery.J Gastroenterol Hepatol. 2015 Aug;30(8):1293-300. doi: 10.1111/jgh.12943. J Gastroenterol Hepatol. 2015. PMID: 25772748
-
Obstructive sleep apnea-hypopnea syndrome and nonalcoholic fatty liver disease: emerging evidence and mechanisms.Semin Liver Dis. 2012 Feb;32(1):49-64. doi: 10.1055/s-0032-1306426. Epub 2012 Mar 13. Semin Liver Dis. 2012. PMID: 22418888 Review.
-
Nonalcoholic fatty liver disease and obstructive sleep apnea.Metabolism. 2016 Aug;65(8):1124-35. doi: 10.1016/j.metabol.2016.05.004. Epub 2016 May 13. Metabolism. 2016. PMID: 27324067 Review.
Cited by
-
Association between sleep apnea and ultrasound-defined liver fibrosis: Results from NHANES 2017 to 2020.Medicine (Baltimore). 2024 Apr 26;103(17):e37949. doi: 10.1097/MD.0000000000037949. Medicine (Baltimore). 2024. PMID: 38669359 Free PMC article.
-
Evaluation of Hepatic Steatosis and Fibrosis Using Transient Elastography in Patients With Obstructive Sleep Apnea.J Clin Exp Hepatol. 2024 Mar-Apr;14(2):101289. doi: 10.1016/j.jceh.2023.09.010. Epub 2023 Sep 30. J Clin Exp Hepatol. 2024. PMID: 38544762
-
Hypoxia-inducible factor-2α promotes fibrosis in non-alcoholic fatty liver disease by enhancing glutamine catabolism and inhibiting yes-associated protein phosphorylation in hepatic stellate cells.Front Endocrinol (Lausanne). 2024 Feb 28;15:1344971. doi: 10.3389/fendo.2024.1344971. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38501098 Free PMC article.
-
Chronic Intermittent Hypoxia-Induced Dysmetabolism Is Associated with Hepatic Oxidative Stress, Mitochondrial Dysfunction and Inflammation.Antioxidants (Basel). 2023 Oct 25;12(11):1910. doi: 10.3390/antiox12111910. Antioxidants (Basel). 2023. PMID: 38001763 Free PMC article.
-
The impact of obstructive sleep apnea on nonalcoholic fatty liver disease.Front Endocrinol (Lausanne). 2023 Oct 2;14:1254459. doi: 10.3389/fendo.2023.1254459. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37850091 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical